Recent Updates
Recently added Catalysts
PODD Positive Sentiment

Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London

Tuesday, November 3, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Insulet Corporation announced its participation in the 2026 Jefferies Global Healthcare Conference in London. The presentation is scheduled for November 18, 2026, at 10:30 a.m. GMT. Investors can access the live webcast and replay on the company's Investor Relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Insulet will present at a major healthcare conference.
  • The event will be accessible via a live webcast.
  • Insulet is recognized as a leader in insulin pump technology.

Full Press Release Details

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the 2026 Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 10:30 a.m. (GMT). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About Insulet Corporation: Insulet Corpor

Frequently Asked Questions

When will Insulet present at the Jefferies Conference?

Insulet will present on November 18, 2026, at 10:30 a.m. GMT.

Where can I watch the Insulet presentation?

The presentation will be available via live webcast on Insulet's website.

What is Insulet known for?

Insulet is a leader in tubeless insulin pump technology.

What is the location of the 2026 Jefferies Conference?

The conference will take place in London.

ShareAdd on Google
Tags: PODD Insulet Jefferies Conference healthcare insulin pump
Last updated: Nov 3, 2026

Biotech snapshot

Cash runway
$535M liquidity · $0M/mo burn
Low dilution risk